Recombinant Production and Purification of Inosine 5-Mono Phosphate Dehydrogenase 1 Retinal Isoforms for Functional Studies
,
Abstract
Inosine 5-monophosphate dehydrogenase 1 (IMPDH1) is the rate-limiting enzyme in the de novo purine nucleotide biosynthesis. IMPDH1 catalyzes IMP-oxidation to XMP, which in continue is converted to guanine nucleotides. Like mammals, the mouse IMPDH1 (mH1) has retinal-specific isoforms named H1 (546) and H1 (603). Mutations in the IMPDH1 gene are believed to cause retinal degenerative disease, retinitis pigmentosa, mediated by retinal-specific gene variants. After RNA extraction from the mouse retina, RT-PCR was done using NdeI and XhoI harboring primers. Tree mH1 isoform genes were amplified and cloned into a pET26b+ vector separately. The recombinant expression vectors were then transformed in E. coli BL21 (DE3) strain, expressed under IPTG-induced conditions and purified with Ni-NTA agarose resin. Activity assay of recombinant proteins was done by using spectrophotometric methods. Here, we cloned and optimized the expression and the purification of recombinant mH1 canonical and retinal isoforms in E. coli to gain soluble and highly active protein for further functional assays. Recombinant protein production in prokaryotic hosts, especially E. coli, is the most common method in large-scale of protein production for functional and structural studies. However, maximal yield and activity of recombinant proteins require optimal conditions for expression and purification, which is what we showed in the present study for the mouse IMPDH1 recombinant isoforms.
2. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis 2006;1:40.
3. Kennan A, Aherne A, Palfi A, Humphries M, McKee A, et al. Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(/) mice. Hum Mol Genet 2002;11:547-57.
4. Bowne S, Sullivan L, Blanton S, Cepko C, Blackshaw S, Birch D, et al. Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. Hum Mol Genet 2002;11:559-68.
5. Bowne S, Sullivan L, Mortimer S, Hedstrom L, Zhu J, Spellicy C, et al. Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis. Invest Ophthalmol Vis Sci 2006;47:34-42.
6. Hedstrom L. IMP dehydrogenase: mechanism of action and inhibition. Curr Med Chem 1999;6:545-60.
7. Natsumeda Y, Ohno S, Kawasaki H, Konno Y, Weber G, Suzuki K. Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem 1990;265:5292-5.
8. Spellicy C, Xu D, Cobb G, Hedstrom L, Bowne S, Sullivan L, et al. Investigating the Mechanism of Disease in the RP10 Form of Retinitis Pigmentosa. Adv Exp Med Biol 2010;664:541-8.
9. Aherne A, Kennan A, Kenna PF, McNally N, Lloyd D, Alberts I, et al. On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa. Hum Mol Genet 2004;13:641-50.
10. Bowne S, Liu Q, Sullivan LS, Zhu J, Spellicy C, Rickman, et al. Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration? Invest Ophthalmol Vis Sci 2006;47:3754-65.
11. Xu D, Cobb G, Spellicy C, Bowne S, Daiger SB, Hedstorm L. Retinal isoforms of inosine 5-monophosphate dehydrogenase type 1 are poor nucleic acid binding proteins. Arch Biochem Biophys 2008;472:100-4.
12. Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. In: Recombinant protein expression in microbial systems. Front Microbiol 2014;5:172,
13. Malik A, Rudolph R, Sohling B. A novel fusion protein system for the production of native human pepsinogen in the bacterial periplasm. Protein Expr Purif 2006;47:662-71.
14. Yang Z, Zhang L, Zhang Y, Zhang T, Feng Y, Lu W, et al. Highly Efficient Production of Soluble Proteins from Insoluble Inclusion Bodies by a Two-Step Denaturing and Refolding Method. PLoS One 2011;6:e22981.
15. Malik A, Jenzsch M, Leubbert A, Rudolph R, Söhling B. Periplasmic production of native human proinsulin as a fusion to E. coli ecotin. Protein Expr Purif 2007;55:100-11.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
17. Spellicy C, Daiger S, Sullivan L, Zhu J, Liu Q, Pierce E. et al. Characterization of retinal inosine monophosphate dehydrogenase 1 in several mammalian species. Mol Vis 2007;13:1866-72.
18. Carr SF, Papp E, Wu JC, Natsumeda Y. Characterization of human type I and type II IMP dehydrogenases. J Biol Chem 1993;268:27286-90.
19. Hager PW, Collart FR, Huberman E, Mitchell BS. Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding. Biochem Pharmacol 1995;49:1323-9.
20. Buey RM, Ledesma-Amaro R, Campoy A, Balsera M, Chagoyen M, De pereda JM. et al. Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases. Nat Commun 2015;6:8923.
21. Wong HH, Kim, YC, Lee SY, Chang HN. Effect of post induction nutrient feeding strategies on the production of bioadhesive protein in Escherichia coli. Biotechnol Bioeng 1998;60:271-6.
22. Block H, Maertens B, Spriestersbach A, Brinker N, Kubicek J, Fabis R, et al. Immobilized-Metal Affinity Chromatography (IMAC): A Review. Methods Enzymol 2009;463:439-73.
23. Gunter GH, Thomas EC, Lengefeld N, Kruger SJ, Worton L, Gardiner EM, et al. Characterisation of inosine monophosphate dehydrogenaze expression during retinal development: differences between variants and isoforms. Int J Biochem Cell Biol 2008;40:1716-28.
| Files | ||
| Issue | Vol 60 No 12 (2022) | |
| Section | Articles | |
| DOI | https://doi.org/10.18502/acta.v60i12.11829 | |
| Keywords | ||
| Expression vector Inosine 5-monophosphate dehydrogenase 1 (IMPDH1) Recombinant protein Retinal isoform | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
